Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
Silke Gillessen(Institute of Oncology Research), Gwénaëlle Gravis(Centre National de la Recherche Scientifique), Christopher J. Sweeney(The University of Adelaide), María T. Bourlon(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Kim N.(Asian Institute of Technology), Karol Axcrona(Norwegian Cancer Society), Eric J. Small(CancerCare Manitoba), Karim Fizazi(Université de Lille), Fabio Turco(Ente Ospedaliero Cantonale), Pierre Blanchard(Inserm), Anders Bjartell(Lund University), Emmanuel S. Antonarakis(University of Minnesota), Felix Y. Feng(University of Michigan), Bertrand Tombal(Cliniques Universitaires Saint-Luc), Ana M. Aparicio(The University of Texas MD Anderson Cancer Center), Nicholas D. James(Royal Marsden NHS Foundation Trust), Daniel Castellano(Universidad Complutense de Madrid), Orazio Caffo(Ospedale Santa Chiara), Thomas Zilli(University of Geneva), Diogo Assed Bastos(Hospital Sírio-Libanês), Alberto Briganti(University College London Hospitals NHS Foundation Trust), Ignacio Durán(Instituto de Biomedicina de Sevilla), Andrew J. Armstrong(Duke University), Omolara Fatiregun(Lagos State University), Heather H. Cheng(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Daniel J. George(Duke University), Himisha Beltran(Dana-Farber Cancer Institute), Jason A. Efstathiou(Massachusetts General Hospital), Caroline S. Clarke(The Royal Free Hospital), Valérie Fonteyne(Ghent University Hospital), Peter C.C. Fong(Royal Marsden NHS Foundation Trust), Louise Emmett(St Vincent's Hospital Sydney), Consuelo Buttigliero(Ospedale San Luigi Gonzaga), Stefano Fanti(Azienda USL di Bologna), Muhammad Bulbul(American University of Beirut Medical Center), Martin Gleave(University of British Columbia), Ian D. Davis(Austin Health), Noel W. Clarke(The Christie NHS Foundation Trust), Johann S. de Bono(Royal Marsden NHS Foundation Trust), Elena Castro(Research Institute Hospital 12 de Octubre), Nicola Fossati(Ospedale regionale di Lugano), Eleni Efstathiou(The University of Texas MD Anderson Cancer Center), Neal D. Shore(Carolina Urologic Research Center), Neeraj Agarwal(University of Utah), Matthew R. Smith(Massachusetts General Hospital), Maria De Santis(Medical University of Vienna), Onyeanunam Ngozi Ekeke(University of Port Harcourt Teaching Hospital), Gerhardt Attard(London Cancer), Tamer I H El Nahas(Cairo University), Mouna Ayadi(Institut Salah-Azaïz)
Cited by 128
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k